CD8A and neoplasm: Since it has been shown that about 70% of cancers are not significantly infiltrated by CD8+ T cells [46], cancer vaccines could allow the priming and intratumoral recruitment of these cells and could transform a “non-inflamed” non-permissive tumor resistant to checkpoint inhibitor blockade into a sensitive “inflamed” tumor [47].